CN Patent

CN103610661B — 一种组合物

Assigned to Dijia Pharmaceutical Group Co ltd · Expires 2017-09-12 · 9y expired

What this patent protects

本发明涉及一种含苯甲酸阿格列汀片组合物。其特征在于，每1000片中含有苯甲酸阿格列汀34g，二氧化硅2‑12g，甘露醇30‑77.5g，微晶纤维素25‑62.5g，交联羧甲纤维素钠6g，羟丙纤维素4g，硬脂酸镁1.5g，欧巴代包衣粉适量。过合理配伍，本发明采用直压工艺，和传统湿法制粒工艺相比简化了生产工艺，缩短了生产时间，提高了生产效率，提高了产品稳定性。

USPTO Abstract

本发明涉及一种含苯甲酸阿格列汀片组合物。其特征在于，每1000片中含有苯甲酸阿格列汀34g，二氧化硅2‑12g，甘露醇30‑77.5g，微晶纤维素25‑62.5g，交联羧甲纤维素钠6g，羟丙纤维素4g，硬脂酸镁1.5g，欧巴代包衣粉适量。过合理配伍，本发明采用直压工艺，和传统湿法制粒工艺相比简化了生产工艺，缩短了生产时间，提高了生产效率，提高了产品稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN103610661B
Jurisdiction
CN
Classification
—
Expires
2017-09-12
Drug substance claim
No
Drug product claim
No
Assignee
Dijia Pharmaceutical Group Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.